Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x10
MRP :
₹144.38
PTR :
₹110
PTS :
₹99
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Viglim M4 is a tablet that carries Glimepiride 4 mg and Metformin 500 mg as its two active ingredients. It belongs to the class of sulfonylurea and biguanide antidiabetic medicines and is packed as 10x10 (Blister) from Vibcare Pharma's Cure division.
Each tablet works on blood sugar in two ways. Glimepiride, the sulfonylurea, acts on the beta cells of the pancreas and encourages the release of more insulin into the bloodstream. Metformin, the biguanide, reduces the amount of glucose produced by the liver and helps the body respond to the insulin it already has.
Viglim M4 is used as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Two serious risks apply: glimepiride can cause severe hypoglycemia, and metformin can rarely cause lactic acidosis, with muscle pain, breathing difficulty, sleepiness and abdominal pain as warning signs.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Viglim M4 tablets combine Glimepiride 4 mg and Metformin 500 mg to improve blood sugar control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; lowers raised blood sugar in adults with type 2 diabetes when diet and exercise alone are not enough; used as one part of the diabetes care plan set by the treating doctor.
Common side effects of Viglim M4 Tablet include low blood sugar (hypoglycemia); headache; dizziness; nausea; weakness or tiredness; diarrhoea and stomach discomfort. Get medical help at once if you notice severe hypoglycemia; lactic acidosis (rare but serious, linked to metformin; symptoms include muscle pain, breathing difficulty, sleepiness and abdominal pain); hemolytic anemia in patients with G6PD deficiency.
Each Viglim M4 tablet contains Glimepiride 4 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim M4 Tablet only as your doctor advises.
The MRP of Viglim M4 Tablet is ₹144.38 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹110 and the PTS is ₹99.
Each Viglim M4 tablet contains Glimepiride 4 mg + Metformin 500 mg. It comes in a pack of 10x10 (Blister).
Each tablet works on blood sugar in two ways. Glimepiride, the sulfonylurea, acts on the beta cells of the pancreas and encourages the release of more insulin into the bloodstream. Metformin, the biguanide, reduces the amount of glucose produced by the liver and helps the body respond to the insulin it already has.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used by patients with severe kidney impairment or any metabolic acidosis. Must not be used by patients allergic to glimepiride, metformin or sulfonamide derivatives. Check with a doctor first if you have reduced kidney or liver function, are 65 years or older, or drink alcohol heavily (these raise the risk of lactic acidosis with metformin). Check with a doctor first if you are pregnant, planning pregnancy or breastfeeding.
Viglim M4 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner